Globus Medical, Inc.
GMED · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8 | $8 | $10 | $11 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | $7 | $8 | $10 | $11 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 3.2% | 24.6% | -9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 63.3% | 66.6% | 67.3% | 59.9% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 28% | 26% | 27.4% | 22.1% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 15.5% | 27.2% | 12.6% | 4% |
| EPS Diluted | 0.88 | 1.49 | 0.54 | 0.19 |
| % Growth | -40.9% | 175.9% | 184.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |